External Validation of the Long Short-Term Memory Artificial Neural Network-Based SCaP Survival Calculator for Prediction of Prostate Cancer Survival
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Decision-making for treatment of newly diagnosed prostate cancer (PCa) is complex due to the multiple initial treatment modalities available. We aimed to externally validate the SCaP (Severance Study Group of Prostate Cancer) Survival Calculator that incorporates a long short-term memory artificial neural network (ANN) model to estimate survival outcomes of PCa according to initial treatment modality. Materials and Methods The validation cohort consisted of clinicopathological data of 4,415 patients diagnosed with biopsy-proven PCa between April 2005 and November 2018 at three institutions. Area under the curves (AUCs) and time-to-event calibration plots were utilized to determine the predictive accuracies of the SCaP Survival Calculator in terms of progression to castration-resistant PCa (CRPC)–free survival, cancer-specific survival (CSS), and overall survival (OS). Results Excellent discrimination was observed for CRPC-free survival, CSS, and OS outcomes, with AUCs of 0.962, 0.944, and 0.884 for 5-year outcomes and 0.959, 0.928, and 0.854 for 10-year outcomes, respectively. The AUC values were higher for all survival endpoints compared to those of the development cohort. Calibration plots showed that predicted probabilities of 5-year survival endpoints had concordance comparable to those of the observed frequencies. However, calibration performances declined for 10-year predictions with an overall underestimation. Conclusion The SCaP Survival Calculator is a reliable and useful tool for determining the optimal initial treatment modality and for guiding survival predictions for patients with newly diagnosed PCa. Further modifications in the ANN model incorporating cases with more extended follow-up periods are warranted to improve the ANN model for long-term predictions.
Abstract
Purpose Decision-making for treatment of newly diagnosed prostate cancer (PCa) is complex due to the multiple initial treatment modalities available. We aimed to externally validate the SCaP (Severance Study Group of Prostate Cancer) Survival Calculator that incorporates a long short-term memory artificial neural network (ANN) model to estimate survival outcomes of PCa according to initial treatment modality. Materials and Methods The validation cohort consisted of clinicopathological data of 4,415 patients diagnosed with biopsy-proven PCa between April 2005 and November 2018 at three institutions. Area under the curves (AUCs) and time-to-event calibration plots were utilized to determine the predictive accuracies of the SCaP Survival Calculator in terms of progression to castration-resistant PCa (CRPC)–free survival, cancer-specific survival (CSS), and overall survival (OS). Results Excellent discrimination was observed for CRPC-free survival, CSS, and OS outcomes, with AUCs of 0.962, 0.944, and 0.884 for 5-year outcomes and 0.959, 0.928, and 0.854 for 10-year outcomes, respectively. The AUC values were higher for all survival endpoints compared to those of the development cohort. Calibration plots showed that predicted probabilities of 5-year survival endpoints had concordance comparable to those of the observed frequencies. However, calibration performances declined for 10-year predictions with an overall underestimation. Conclusion The SCaP Survival Calculator is a reliable and useful tool for determining the optimal initial treatment modality and for guiding survival predictions for patients with newly diagnosed PCa. Further modifications in the ANN model incorporating cases with more extended follow-up periods are warranted to improve the ANN model for long-term predictions.
참고문헌 (20)
- Ha Chung B, "The incidence, mortality, and risk factors of prostate cancer in Asian men", Prostate Int, 7, pp.1~8 (2019)
- Mohler JL, "Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology", J Natl Compr Canc Netw, 17, pp.479~505 (2019)
- Sanda MG, "Clinically localized prostate cancer: AUA", ASTRO, J Urol, pp.2018, 199[DOI]
- Martinez-Gonzalez NA, "Shared decision-making for prostate cancer screening and treatment : a systematic review of randomised controlled trials", Swiss Med Wkly, 148, pp.w14584~ (2018)
- Cuypers M, "The impact of prostate cancer diagnosis and treatment decision-making on health-related quality of life before treatment onset", Support Care Cancer, 26, pp.1297~1304 (2018)
- Mottet N, "EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent", Eur Urol, 71, pp.618~629 (2017)
- Spelt L, "Artificial neural networks : a method for prediction of survival following liver resection for colorectal cancer metastases", Eur J Surg Oncol, 39, pp.648~654 (2013)
- Peng JH, "A scoring system based on artificial neural network for predicting 10-year survival in stage II A colon cancer patients after radical surgery", Oncotarget, 7, pp.22939~22947 (2016)
- Kourou K, "Machine learning applications in cancer prognosis and prediction", Comput Struct Biotechnol J, 13, pp.8~17 (2015)
- Koo KC, "Long short-term memory artificial neural network model for prediction of prostate cancer survival outcomes according to initial treatment strategy : development of an online decisionmaking support system", World J Urol, 38, pp.2469~2476 (2020)
- "Natural resources biometrics. Chapter 7: Correlation and simple linear regression" (2014)[URL]
- van Kleef JJ, "External validation of the Dutch SOURCE survival prediction model in Belgian metastatic oesophageal and gastric cancer patients", Cancers(Basel), 12, pp.834~ (2020)
- D’Amico AV, "Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer", J Clin Oncol, 20, pp.4567~4573 (2002)
- Cooperberg MR, "Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis", J Natl Cancer Inst, 101, pp.878~887 (2009)
- Oh SE, "Prediction of overall survival and novel classification of patients with gastric cancer using the survival recurrent network", Ann Surg Oncol, 25, pp.1153~1159 (2018)
- Obrzut B, "Prediction of 5-year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods", BMC Cancer, 17, pp.840~ (2017)
- Qiao G, "Artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma", J Gastroenterol Hepatol, 29, pp.2014~2020 (2014)
- Snow PB, "Artificial neural networks in clinical urology", Urology, 54, pp.787~790 (1999)
- Steyerberg EW, "Assessing the performance of prediction models : a framework for traditional and novel measures", Epidemiology, 21, pp.128~138 (2010)
- Collins GS, "Sample size considerations for the external validation of a multivariable prognostic model : a resampling study", Stat Med, 35, pp.214~226 (2016)